Trials / Completed
CompletedNCT07297316
Immediate Therapeutic Effects of Diquafosol and Rebamipide in Dry Eye Disease
Comparison of Immediate Therapeutic Effects of 3% Diquafosol and 2% Rebamipide in Dry Eye Disease
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Korea University Anam Hospital · Academic / Other
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Not accepted
Summary
This study compares the immediate therapeutic and mucin-secreting effects 30 minutes after instillation of 3% diquafosol and 2% rebamipide in dry eye disease.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | 3% diquafosol (right eye) and 2% rebamipide (left eye) | 3% diquafosol was instilled in the right eye and 2% rebamipide in the left eye. |
| DRUG | 2% rebamipide (right eye) and 3% diquafosol (left eye) | 2% rebamipide was instilled in the right eye and 3% diquafosol in the left eye. |
Timeline
- Start date
- 2022-10-03
- Primary completion
- 2024-08-30
- Completion
- 2024-08-30
- First posted
- 2025-12-22
- Last updated
- 2025-12-22
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT07297316. Inclusion in this directory is not an endorsement.